Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central anxious program, conolidine modulates alternate molecular targets. A Science Innovations review discovered that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://hindibookmark.com/story22321325/conolidin-to-replace-traditional-painkillers-options